http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009038656-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3b8162ef13bb7b0d0fd355dff2f05db9 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-549 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-385 |
| filingDate | 2008-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b95d19664ede92700ee460d2455ddc26 |
| publicationDate | 2009-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2009038656-A1 |
| titleOfInvention | Mitochondria-targeting antioxidant therapeutics |
| abstract | The instant invention constitutes an unique subject matter as a whole which has four individual aspects: (1) a class of chiral, non- racemic, synthetic carnitinoid analog carrier molecules which constitute biocompatible transport compounds not found in nature; (2) a subsequently formed, mitochondria-targeting, coupled antioxidant-carrier complex comprising an antioxidant reversibly attached to and releasable from the synthetic carrier molecule; (3) a method for introducing a biologically active antioxidant into the interior of mitochondria of a living cell for subsequent reaction with such reactive oxygen species may then be present; and (4) a system for delivering a biologically active antioxidant to the interior of mitochondria within a living cell. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11590158-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11135239-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108218732-A |
| priorityDate | 2007-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 364.